they got it very wrong - ouch. That's only in the short term, in the medium to longer it will prove to be cheap.
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025